Related references
Note: Only part of the references are listed.A Single-Dose Combination Study with the Experimental Antimalarials Artefenomel and DSM265 To Determine Safety and Antimalarial Activity against Blood-Stage Plasmodium falciparum in Healthy Volunteers
James S. McCarthy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites
Jakob Birnbaum et al.
SCIENCE (2020)
Uncovering the ART of antimalarial resistance
Danushka Marapana et al.
SCIENCE (2020)
Role of Plasmodium falciparum Kelch 13 Protein Mutations in P. falciparum Populations from Northeastern Myanmar in Mediating Artemisinin Resistance
Faiza Amber Siddiqui et al.
MBIO (2020)
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
Rob W. van der Pluijm et al.
LANCET (2020)
Emergence and clonal expansion of in vitro artemisinin-resistantPlasmodium falciparum kelch13R561H mutant parasites in Rwanda
Aline Uwimana et al.
NATURE MEDICINE (2020)
The past, present and future of anti-malarial medicines
Edwin G. Tse et al.
MALARIA JOURNAL (2019)
Rare mutations in Pfmdr1 gene of Plasmodium falciparum detected in clinical isolates from patients treated with anti-malarial drug in Nigeria
Abel O. Idowu et al.
MALARIA JOURNAL (2019)
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
Nicholas J. White
MALARIA JOURNAL (2019)
Decreased K13 Abundance Reduces Hemoglobin Catabolism and Proteotoxic Stress, Underpinning Artemisinin Resistance
Tuo Yang et al.
CELL REPORTS (2019)
PfVPS45 Is Required for Host Cell Cytosol Uptake by Malaria Blood Stage Parasites
Ernst Jonscher et al.
CELL HOST & MICROBE (2019)
Combination drug therapy via nanocarriers against infectious diseases
Pavan Walvekar et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay
Jerzy M. Dziekan et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Imidazolopiperazines Kill both Rings and Dormant Rings in Wild-Type and K13 Artemisinin-Resistant Plasmodium falciparum In Vitro
Laurent Dembele et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Drug targets for resistant malaria: Historic to future perspectives
Sahil Kumar et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Drugs in Development for Malaria
Elizabeth A. Ashley et al.
DRUGS (2018)
DSM265: a novel drug for single-dose cure of Plasmodium falciparum malaria
Sabine Belard et al.
LANCET INFECTIOUS DISEASES (2018)
Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study
Roberto Amato et al.
LANCET INFECTIOUS DISEASES (2018)
Effectiveness and safety of 3 and 5 day courses of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar
Kyaw Myo Tun et al.
MALARIA JOURNAL (2018)
Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda
Vito Baraka et al.
PLOS ONE (2018)
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Rahul P. Bakshi et al.
NATURE COMMUNICATIONS (2018)
Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis
Frank Kloprogge et al.
PLOS MEDICINE (2018)
How to combat emerging artemisinin resistance: Lessons from The Three Little Pigs
Thanat Chookajorn
PLOS PATHOGENS (2018)
Chemical Proteomics and Super-resolution Imaging Reveal That Chloroquine Interacts with Plasmodium falciparum Multidrug Resistance-Associated Protein and Lipids
John G. Woodland et al.
ACS CHEMICAL BIOLOGY (2018)
Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling
Saber Dini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Mechanisms of resistance to the partner drugs of artemisinin in the malaria parasite
Rowena E. Martin et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
Leila S. Ross et al.
NATURE COMMUNICATIONS (2018)
Artemisinin Resistance Outside of Southeast Asia
Philip J. Rosenthal
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Evidence of Artemisinin-Resistant Plasmodium falciparum Malaria in Eastern India
Sabyasachi Das et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination
Manel Ouji et al.
PARASITE (2018)
Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity
Sonia Agrawal et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial
Ousmane A. Koita et al.
LANCET INFECTIOUS DISEASES (2017)
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
James S. McCarthy et al.
LANCET INFECTIOUS DISEASES (2017)
The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study
Mallika Imwong et al.
LANCET INFECTIOUS DISEASES (2017)
Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study
Roberto Amato et al.
LANCET INFECTIOUS DISEASES (2017)
Emergence of Plasmodium falciparum triple mutant in Cambodia
Gabriele Rossi et al.
LANCET INFECTIOUS DISEASES (2017)
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study
Benoit Witkowski et al.
LANCET INFECTIOUS DISEASES (2017)
Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia
Angana Mukherjee et al.
MALARIA JOURNAL (2017)
Seasonal malaria chemoprevention: successes and missed opportunities
Matthew E. Coldiron et al.
MALARIA JOURNAL (2017)
Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition
Saikat Dewanjee et al.
MOLECULES (2017)
A genetic system to study Plasmodium falciparum protein function
Jakob Birnbaum et al.
NATURE METHODS (2017)
Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase
Tanya Paquet et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A Variant PfCRT Isoform Can Contribute to Plasmodium falciparum Resistance to the First-Line Partner Drug Piperaquine
Satish K. Dhingra et al.
MBIO (2017)
Plasmodium falciparum K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness In Vitro
Judith Straimer et al.
MBIO (2017)
Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity
Manu Vanaerschot et al.
NATURE MICROBIOLOGY (2017)
Hitting malaria where it hurts
Thierry Diagana et al.
Nature Microbiology (2017)
Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis
Wilson Wong et al.
NATURE MICROBIOLOGY (2017)
The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites
L. Dembele et al.
SCIENTIFIC REPORTS (2017)
Longitudinal genomic surveillance of Plasmodium falciparum malaria parasites reveals complex genomic architecture of emerging artemisinin resistance
Gustavo C. Cerqueira et al.
GENOME BIOLOGY (2017)
Emergence of Mutations in the K13 Propeller Gene of Plasmodium falciparum Isolates from Dakar, Senegal, in 2013-2014
Agathe Boussaroque et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Monoclonal Antibodies That Recognize the Alkylation Signature of Antimalarial Ozonides OZ277 (Arterolane) and OZ439 (Artefenomel)
Joelle Jourdan et al.
ACS INFECTIOUS DISEASES (2016)
Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways
Erik L. Allman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Discovery and Characterization of ACT-451840: an Antimalarial Drug with a Novel Mechanism of Action
Christoph Boss et al.
CHEMMEDCHEM (2016)
Can new treatment developments combat resistance in malaria?
Nicholas J. White
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Innovation in the pharmaceutical industry: New estimates of R&D costs
Joseph A. DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2016)
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
Aung Pyae Phyo et al.
LANCET INFECTIOUS DISEASES (2016)
Plasmodium falciparum: multifaceted resistance to artemisinins
Lucie Paloque et al.
MALARIA JOURNAL (2016)
CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs
Caroline L. Ng et al.
MOLECULAR MICROBIOLOGY (2016)
Structure- and function-based design of Plasmodium-selective proteasome inhibitors
Hao Li et al.
NATURE (2016)
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms
D. Menard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria
Nicholas J. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Artemisinin Action and Resistance in Plasmodium falciparum
Leann Tilley et al.
TRENDS IN PARASITOLOGY (2016)
Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies
M. Isabel Veiga et al.
NATURE COMMUNICATIONS (2016)
Gametocyte clearance dynamics following oral artesunate treatment of uncomplicated falciparum malaria in Malian children
Abdoulaye A. Djimde et al.
PARASITE (2016)
Impact of Antimalarial Treatment and Chemoprevention on the Drug Sensitivity of Malaria Parasites Isolated from Ugandan Children
Patrick Tumwebaze et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment
Rithea Leang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Fosmidomycin as an antimalarial drug: a meta-analysis of clinical trials
Jose Francisco Fernandes et al.
FUTURE MICROBIOLOGY (2015)
Fitness of artemisinin-resistant Plasmodium falciparum in vitro
Amanda Hott et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Mitochondrial Membrane Potential in a Small Subset of Artemisinin-Induced Dormant Plasmodium falciparum Parasites In Vitro
Christopher L. Peatey et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data
N. M. Anstey et al.
LANCET INFECTIOUS DISEASES (2015)
Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study
Michele D. Spring et al.
LANCET INFECTIOUS DISEASES (2015)
A novel multiple-stage antimalarial agent that inhibits protein synthesis
Beatriz Baragana et al.
NATURE (2015)
The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015
S. Bhatt et al.
NATURE (2015)
Genetic architecture of artemisinin-resistant Plasmodium falciparum
Olivo Miotto et al.
NATURE GENETICS (2015)
Dried whole-plant Artemisia annua slows evolution of malaria drug resistance and overcomes resistance to artemisinin
Mostafa A. Elfawal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The discovery of artemisinin and the Nobel Prize in Physiology or Medicine
Su Xin-Zhuan et al.
SCIENCE CHINA-LIFE SCIENCES (2015)
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
Margaret A. Phillips et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations
Bryan T. Mott et al.
SCIENTIFIC REPORTS (2015)
Targeting the Cell Stress Response of Plasmodium falciparum to Overcome Artemisinin Resistance
Con Dogovski et al.
PLOS BIOLOGY (2015)
African Glucose-6-Phosphate Dehydrogenase Alleles Associated with Protection from Severe Malaria in Heterozygous Females in Tanzania
Alphaxard Manjurano et al.
PLOS GENETICS (2015)
The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs
Natalie Jane Spillman et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2015)
First-in-Humans Study of the Safety, Tolerability, and Pharmacokinetics of ACT-451840, a New Chemical Entity with Antimalarial Activity
Shirin Bruderer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia
Shannon Takala-Harrison et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates
Judith Straimer et al.
SCIENCE (2015)
Evolution from double to triple-antimalarial drug combinations
G. Dennis Shanks et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2015)
Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P-falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine
Meera Venkatesan et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2014)
Fatty Acid Synthesis and Pyruvate Metabolism Pathways Remain Active in Dihydroartemisinin-Induced Dormant Ring Stages of Plasmodium falciparum
Nanhua Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
F. Joel Leong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Complex Polymorphisms in the Plasmodium falciparum Multidrug Resistance Protein 2 Gene and Its Contribution to Antimalarial Response
Maria Isabel Veiga et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission
Kelli L. Kuhen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Rapid kill of malaria parasites by artemisinin and semi-synthetic endoperoxides involves ROS-dependent depolarization of the membrane potential
Thomas Antoine et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Plasmodium falciparum multidrug resistance protein 1 (pfmrp1) gene and its association with in vitro drug susceptibility of parasite isolates from north-east Myanmar
Bhavna Gupta et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Artemisinin resistance - modelling the potential human and economic costs
Yoel Lubell et al.
MALARIA JOURNAL (2014)
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frederic Ariey et al.
NATURE (2014)
Spiroindolone KAE609 for Falciparum and Vivax Malaria
Nicholas J. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Dihydroartemisinin-Piperaquine Failure in Cambodia
David L. Saunders et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium
Maria Belen Jimenez-Diaz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Defining the biology component of the drug discovery strategy for malaria eradication
Didier Leroy et al.
TRENDS IN PARASITOLOGY (2014)
Insights into the Role of Heme in the Mechanism of Action of Antimalarials
Jill M. Combrinck et al.
ACS CHEMICAL BIOLOGY (2013)
Mefloquine Exposure Induces Cell Cycle Delay and Reveals Stage-Specific Expression of the pfmdr1 Gene
Elaine B. Bohorquez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Na+ Regulation in the Malaria Parasite Plasmodium falciparum Involves the Cation ATPase PfATP4 and Is a Target of the Spiroindolone Antimalarials
Natalie J. Spillman et al.
CELL HOST & MICROBE (2013)
UV-triggered Affinity Capture Identifies Interactions between the Plasmodium falciparum Multidrug Resistance Protein 1 (PfMDR1) and Antimalarial Agents in Live Parasitized Cells
Ralf Brunner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies
Benoit Witkowski et al.
LANCET INFECTIOUS DISEASES (2013)
The interplay between drug resistance and fitness in malaria parasites
Philip J. Rosenthal
MOLECULAR MICROBIOLOGY (2013)
Fast in vitro methods to determine the speed of action and the stage-specificity of anti-malarials in Plasmodium falciparum
Claire Le Manach et al.
MALARIA JOURNAL (2013)
Designing the next generation of medicines for malaria control and eradication
Jeremy N. Burrows et al.
MALARIA JOURNAL (2013)
Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity
Kesara Na-Bangchang et al.
MALARIA JOURNAL (2013)
Timing is everything for artemisinin action
David J. Sullivan
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Altered temporal response of malaria parasites determines differential sensitivity to artemisinin
Nectarios Klonis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
3,5-Diaryl-2-aminopyridines as a Novel Class of Orally Active Antimalarials Demonstrating Single Dose Cure in Mice and Clinical Candidate Potential
Yassir Younis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Effects of Antimalarial Molecules on the Gametocyte Stage of Plasmodium falciparum: The Debate
Odile Dechy-Cabaret et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Activity of Clinically Relevant Antimalarial Drugs on Plasmodium falciparum Mature Gametocytes in an ATP Bioluminescence Transmission Blocking Assay
Joel Lelievre et al.
PLOS ONE (2012)
Similar Efficacy and Tolerability of Double-Dose Chloroquine and Artemether-Lumefantrine for Treatment of Plasmodium falciparum Infection in Guinea-Bissau: A Randomized Trial
Johan Ursing et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential
Jose M. Coteron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
PfMDR1: Mechanisms of Transport Modulation by Functional Polymorphisms
Pedro Eduardo Ferreira et al.
PLOS ONE (2011)
Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue
Sophie H. Adjalley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion
Nectarios Klonis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
Susan A. Charman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Proliferation/quiescence: the controversial aller-retour
Bertrand Daignan-Fornier et al.
CELL DIVISION (2011)
Quinolines and structurally related heterocycles as antimalarials
Kirandeep Kaur et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Spirotetrahydro β-Carbolines (Spiroindolones): A New Class of Potent and Orally Efficacious Compounds for the Treatment of Malaria
Bryan K. S. Yeung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT type
Juliana M. Sa et al.
MALARIA JOURNAL (2010)
Malaria's Drug Miracle in Danger
Martin Enserink
SCIENCE (2010)
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Matthias Rottmann et al.
SCIENCE (2010)
Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent
Carmony L. Hartwig et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Artemisia Species: From Traditional Medicines to Modern Antimalarials-and Back Again
Merlin Willcox
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2009)
In Vivo Selection of Plasmodium falciparum Parasites Carrying the Chloroquine-Susceptible pfcrt K76 Allele after Treatment with Artemether-Lumefantrine in Africa
Christin Sisowath et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Polymorphisms within PfMDR1 alter the substrate specificity for anti-malarial drugs in Plasmodium falciparum
Cecilia P. Sanchez et al.
MOLECULAR MICROBIOLOGY (2008)
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Harald Noedl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Formation of the Food Vacuole in Plasmodium falciparum: A Potential Role for the 19 kDa Fragment of Merozoite Surface Protein 1 (MSP119)
Anton R. Dluzewski et al.
PLOS ONE (2008)
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen
David Plouffe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Qinghaosu (Artemisinin): The price of success
N. J. White
SCIENCE (2008)
Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasites
Paul Hunt et al.
MOLECULAR MICROBIOLOGY (2007)
Transporters involved in resistance to antimalarial drugs
Stephanie G. Valderramos et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
The silent path to thousands of merozoites:: the Plasmodium liver stage
Miguel Prudencio et al.
NATURE REVIEWS MICROBIOLOGY (2006)
Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin
Amar Bir Singh Sidhu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum
Petra Rohrbach et al.
EMBO JOURNAL (2006)
Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y
G Holmgren et al.
INFECTION GENETICS AND EVOLUTION (2006)
Targeting of hematin by the antimalarial pyronaridine
Saranya Auparakkitanon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Primaquine: Report from CDC expert meeting on malaria chemoprophylaxis I
David R. Hill et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2006)
pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum
ABS Sidhu et al.
MOLECULAR MICROBIOLOGY (2005)
Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia
N Khim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Contribution of the pfmdr1 gene to antimalarial drug-resistance
MT Duraisingh et al.
ACTA TROPICA (2005)
In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem)
C Sisowath et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Mutations in pfmdr1 modulate the sensitivity of Plasmodium falciparum to the intrinsic antiplasmodial activity of verapamil
R Hayward et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs
CD Fitch
LIFE SCIENCES (2004)
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number
RN Price et al.
LANCET (2004)
Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques
S Ramanathan-Girish et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2004)
Acidification of the malaria parasite's digestive vacuole by a H+-ATPase and a H+-pyrophosphatase
KJ Saliba et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The evolution of drug-resistant malaria: the role of drug elimination half-life
IM Hastings et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES (2002)
Heme-artemisinin adducts are crucial mediators of the ability of artemisinin to inhibit heme polymerization
R Kannan et al.
CHEMISTRY & BIOLOGY (2002)
Chloroquine-resistant malaria
TE Wellems et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
The public health impact of chloroquine resistance in Africa
JF Trape
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2001)
Mutations in the P-falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance
DA Fidock et al.
MOLECULAR CELL (2000)
Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum
MB Reed et al.
NATURE (2000)
Share Paper
